HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pecksniff's

This article was originally published in The Rose Sheet

Executive Summary

English fragrance house will launch colorful Aromasensory and contemporary Mood Therapy fragrance ranges in U.S. department and specialty stores this fall, Brighton, UK company says. Approximately 48 of Pecksniff's 500 SKUs initially will debut stateside. Both ranges include four fragrances in six product forms including foam bath, shower gel, bath salts and massage oils. Aromasensory fragrances range from light, fresh accords to warm, musk scents and will be available in Grapefruit & Berry, Lavender & Basil, Rose & Jasmine and Sandalwood & Vanilla. Mood Therapy range, formulated with 100% pure essential oils, will be available in Alive, Calm, Happy and Naughty. Product prices average approximately $15, firm says. Founded in 1982, Pecksniff's is sold in England through two stand-alone stores in London and Brighton, as well as department stores such as Harrod's and House of Fraser

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009181

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel